Glaucoma Drainage Devices Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos
The growth of the
glaucoma drainage devices market across the globe is witnessing growth on
account of the rising global burden of glaucoma and the surge in the number of
glaucoma care initiatives by the government and other private organizations. For instance, according to the data
estimated by the American Academy of Ophthalmology (AAO), the global prevalence
of glaucoma was estimated to reach 76 million by 2020 and further is expected
to reach 111.8 million by 2040. Furthermore, favorable reimbursement policies and foreign direct
investment provisions are some of the other prominent factors contributing to
the growth of the market.
According to UnivDatos Market Insights (UMI)โ research
report โGlobal Glaucoma
Drainage Devices Market Analysis, 2021โ, the glaucoma drainage devices market is projected
to grow at a CAGR of ~5% during 2021-27F. The demand for glaucoma drainage
devices is increasing on account of the growing number of people having
diabetes as it is one of the major risk factors that may lead to glaucoma
development.
๐๐จ ๐๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐๐ฎ๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐
๐๐จ๐ฉ๐ฒ - https://univdatos.com/get-a-free-sample-form-php/?product_id=20901
Based on the product
type, the market is fragmented into conventional
glaucoma drainage devices, minimally invasive glaucoma surgery devices, and
others. The conventional glaucoma drainage devices segment accounted for a considerable
share in 2020 and is anticipated to register a lucrative CAGR during the
forecast period. The growth of this segment can be attributed to the adoption
of conventional glaucoma surgery as the first choice of treatment in
underdeveloped nations as the cost of conventional devices are low as compared
to minimally invasive glaucoma surgery devices.
Hospitals Segment to Witness Robust growth
Based on end-users, the market is segmented into
hospitals, specialty clinics, ambulatory surgical centers, and others. The hospital
segment had the highest revenue and CAGR growth in the analyzed period owing to
the presence of several advanced surgical devices and the availability of
highly skilled healthcare professionals in hospitals.
North America to Grab
Lionโs Share, and witnessed Explicit Growth
Based on the region, North America dominated
the global glaucoma drainage devices market in 2020. The region is projected to
maintain its dominance during the forecasted period 2021-27 owing to the rapidly
growing prevalence of glaucoma and well-established market players. North
America is expected to skyrocket with a CAGR of XX% in the forecast period
owing, as stated in UnivDatos Market Insights (UMI)โ
research report โGlobal Glaucoma Drainage Devices Analysis,
2021โ.
๐๐จ ๐๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐๐ฎ๐ฅ ๐๐๐ฌ๐๐๐ซ๐๐ก, ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐
๐๐จ๐ฉ๐ฒ - https://univdatos.com/get-a-free-sample-form-php/?product_id=20901
According
to UnivDatos Market Insights (UMI)โ,
the key players with a considerable market share in the Glaucoma Drainage
Devices Market include Aurolab, Johnson &
Johnson Vision Care, Inc., Rheon Medical SA, Allergan (AbbVie), NovaEye
Medical, Novartis AG, Glaukos Corporation, iSTAR Medical, Ivantis Inc., New
World Medical, Inc., among
others. The players are focused on launching products for gaining customers'
traction and expanding their geographical reach to get a competitive edge in
the industry.
โGlobal Glaucoma
Drainage Devices Market Analysis,
2021โ provides
comprehensive qualitative and quantitative insights on the industry potential,
key factors impacting sales and purchase decisions, hotspots, and opportunities
available for glaucoma drainage devices providers across the Globe. Moreover,
the report also encompasses the key strategic imperatives for success for
competitors along with strategic factorial indexing measuring competitor's
capabilities on 16 parameters. This will help companies in the formulation of go
to Market Strategies and identifying the blue ocean for its offerings.
For more informative information, please visit
us โ https://univdatos.com/report/glaucoma-drainage-devices-market/
Market Segmentation:
1. By Product Type (Conventional Glaucoma Drainage Devices, Minimally Invasive Glaucoma
Surgery Devices, and Others)
2. By End-Users (Hospitals,
Specialty Clinics, Ambulatory Surgical Centers, and Others)
3.
By Region (North America,
Europe, Asia-Pacific, Rest of the World)
4.
By Company (Aurolab,
Johnson & Johnson Vision Care, Inc., Rheon Medical SA, Allergan (AbbVie),
NovaEye Medical, Novartis AG, Glaukos Corporation, iSTAR Medical, Ivantis Inc.,
New World Medical, Inc., etc.)
Key
questions answered in the study:
1.
What are the current and future trends
in the glaucoma drainage devices industry?
2.
How the industry has been evolving in
terms of product type, and end-users?
3.
How the competition has been shaping
across the countries followed by their comparative factorial indexing?
4.
What are the key growth drivers and
challenges for the glaucoma drainage devices industry?
5.
What is the customer orientation,
purchase behavior, and expectations from the glaucoma drainage devices firms
across various regions?
Table
of Content โ
1 MARKET INTRODUCTION
2 RESEARCH METHODOLOGY OR ASSUMPTION
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 COVID-19 IMPACT
6 GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET
REVENUE
7 MARKET INSIGHTS BY PRODUCT TYPE
8 MARKET INSIGHTS BY END-USERS
9 MARKET INSIGHTS BY REGION
10 GLAUCOMA DRAINAGE DEVICES MARKET DYNAMICS
11 GLAUCOMA DRAINAGE DEVICES MARKET
OPPORTUNITIES
12 GLAUCOMA DRAINAGE DEVICES MARKET TRENDS
& INSIGHTS
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY SIDE ANALYSIS
15 VALUE CHAIN ANALYSIS
16 COMPETITIVE SCENARIO
17 COMPANY PROFILED
18 DISCLAIMER
Browse Other Related Research Reports from UnivDatos
Market Insights
ยท
In-Vitro
Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR:
5.24%|
ยท Critical
Care Equipment Market to Reach US$ 38 Billion by 2026 Globally |CAGR: 6%|
Labels: Glaucoma Drainage Devices Market
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home